Industry / France
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
OTC Sector Growing In Importance
November 2007 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
BMI has revised its forecasts for the French over-the-counter (OTC) drug sales, as the government looks to shift 5% of volume sales form the prescription to the OTC sector. Although the details of the final plan are still being negotiated, BMI is confident that the authorities will be at least partially successful in their efforts. Subsequently we expect the share of the OTC drugs will grow over the next five years to reach 10% of the total market, or US$3.1bn.